Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

AB027. New progress in the study of erectile dysfunction in the American Urological Association’s 2018 Annual Meeting

Prospective Study on Systemic / IV, published in Transl Androl Urol (2018) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Transl Androl Urol (2018)
Reported sample size
—
Source database
Europe PMC
PMCID
PMC6186712

Abstract (original English)

It is estimated that 150 million men worldwide are affected by erectile dysfunction (ED). In terms of risk factors, independent risk factors for ED include age, smoking, diabetes, hypertension, dyslipidemia, depression, obesity, and sedentary lifestyle. Besides, sleep disorders are potential risk factors for ED, so men who are troubled with loss of diurnal rhythm have significant worse erection. In addition, serum cadmium levels can be used as an independent predictor of erectile function. In terms of diagnosis and evaluation, penile color Doppler ultrasound can effectively evaluate the presence of vascular factors in patients with ED, and has a good correlation with angiographic results, which can be used as a non-invasive examination before angiography. As for treatment, penile prosthesis can effectively improve the erectile function of patients, and posttreatment score is higher on the quality of sexual life and satisfaction of sexual performance. In addition, it is reported that diabetes is an important factor affecting the quality of sexual life after the first penis implant. What’s more, prosthesis implantation will not lead to complications such as shortening of the penis length and decreased sensitivity. However, studies such as extracorporeal shock wave therapy, recovery of erectile function after prostate cancer surgery (sural nerve grafting, intraoperative tissue sea

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research